Your session is about to expire
← Back to Search
Financial Navigation Program for Cancer (CREDIT Trial)
N/A
Recruiting
Led By Veena Shankaran
Research Sponsored by Southwest Oncology Group
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients must have a Zubrod performance status of 0-2
Patients must complete the baseline patient reported outcomes (PRO) questionnaires prior to registration and must be able to complete questionnaires in English or Spanish
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 12 months
Awards & highlights
CREDIT Trial Summary
This trial is testing a financial navigation program to help cancer patients and their spouses understand and manage the financial aspects of cancer care. The goal is to reduce financial worries and improve quality of life.
Who is the study for?
This trial is for adult cancer patients with metastatic solid tumors or blood cancers starting treatment within 60 days of diagnosis, and their spouses who live together and can complete questionnaires in English or Spanish. Excluded are those on hospice care, with indolent diseases under observation only, or diagnosed with a secondary malignancy within the last 24 months unless it's specific non-active skin cancers.Check my eligibility
What is being tested?
The study tests a financial navigation program designed to help cancer patients and their spouses manage treatment costs. It involves education, patient navigation support, quality-of-life assessments, and completing questionnaires to evaluate the program's effectiveness in reducing financial stress.See study design
What are the potential side effects?
There are no medical side effects as this is not a drug trial; however participants may experience emotional discomfort discussing personal finances or when dealing with sensitive information such as credit reports.
CREDIT Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I can take care of myself and am up and about more than 50% of my waking hours.
Select...
I have completed the required questionnaires in English or Spanish before signing up.
Select...
I am 18 years old or older.
Select...
I will start cancer treatment within 30 days of signing up.
CREDIT Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Household financial hardship
Secondary outcome measures
Financial worry
Quality of life: patient
Quality of life: spouse
+1 moreOther outcome measures
Community/clinic assistance
Emergency department/hospital use
Qualitative assessment of the intervention
+1 moreCREDIT Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Group II (financial navigation intervention)Experimental Treatment4 Interventions
Patients and spouse caregivers receive financial literacy training consisting of watching online educational videos over 2-8 minutes. Patients also meet with CENTS counselor and PAF case manager over approximately 1 hour every month for 6 months (with each group). Patients and spouses also complete questionnaires over 30-60 minutes about education, employment, finances (assets, debt), insurance, and quality of life (financial worry) and have credit reports assessed at baseline and 3, 6, and 12 months.
Group II: Group I (usual care)Active Control3 Interventions
Patients and spouse caregivers receive financial literacy training consisting of watching online educational videos over 2-8 minutes. Patients and spouses also complete questionnaires over 30-60 minutes about education, employment, finances (assets, debt), insurance, and quality of life (financial worry) and have credit reports assessed at baseline and 3, 6, and 12 months.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Patient Navigation
2017
Completed Phase 2
~38910
Find a Location
Who is running the clinical trial?
Southwest Oncology GroupLead Sponsor
388 Previous Clinical Trials
260,739 Total Patients Enrolled
SWOG Cancer Research NetworkLead Sponsor
394 Previous Clinical Trials
264,098 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,660 Previous Clinical Trials
40,923,571 Total Patients Enrolled
1 Trials studying Blood Cancers
70 Patients Enrolled for Blood Cancers
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I can take care of myself and am up and about more than 50% of my waking hours.I have completed the required questionnaires in English or Spanish before signing up.My cancer has returned, but it's the first time it has spread, and it was diagnosed 6 months after my initial cancer diagnosis.I started my cancer treatment less than 60 days ago.My spouse, who is my caregiver, lives with me.I am 18 years old or older.I was diagnosed with cancer that has spread or is a blood cancer, and I'm getting treatment within 4 months of diagnosis.I am a spouse caregiver and I am 18 years old or older.I can provide my email and phone number for contact.My spouse will provide their contact details for financial guidance.My spouse can complete questionnaires in English or Spanish and will do so before I register.I had cancer before, but it's been over 2 years, I'm not on treatment, and I'm cancer-free now.I will start cancer treatment within 30 days of signing up.
Research Study Groups:
This trial has the following groups:- Group 1: Group I (usual care)
- Group 2: Group II (financial navigation intervention)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Blood Cancers Patient Testimony for trial: Trial Name: NCT04960787 — N/A
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any vacancies for individuals interested in participating in this trial?
"Indeed, the information on clinicaltrials.gov specifies that recruitment for this medical trial is actively underway. The study was first published on July 15th 2021 and recently modified on March 29th 2022."
Answered by AI
In what capacity are medical facilities participating in this research?
"This medical research is recruiting patients from the Delaware Health Center-Grady Cancer Centre in Ohio, HaysMed University of Kansas Health System in Kansa and Kaiser Permanente-South San Francisco in Illinois. Furthermore, there are another 100 sites enrolling people for this experiment."
Answered by AI
What is the participant capacity for this clinical research?
"This trial necessitates the inclusion of 1072 volunteers that meet the prerequisites. Delaware Health Center-Grady Cancer Center in Delaware, Ohio and HaysMed University of Kansas Health System in Hays are two locations where participants may enroll."
Answered by AI
Who else is applying?
What state do they live in?
Missouri
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
0
What questions have other patients asked about this trial?
We are in South Central Missouri, is there a home based or closer location to us?
PatientReceived 1 prior treatment
Why did patients apply to this trial?
My husband has CLL and we are worried about the financial situation that will inevitably come our way.
PatientReceived 1 prior treatment
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger